Avail 30% Discount Now: Premium Insights at Discounted Price (Discount will be Applied at Checkout)

Global Ankylosing Spondylitis Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

Segmented by Drug;

Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia and Others.

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2018 - 2028).
Report ID: Rn154136516 Published Date: November, 2022 Updated Date: December, 2022

Introduction

Global Ankylosing Spondylitis Market (USD Million), 2018 - 2028

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2018 - 2028
2018 68.5
2019 71.8
2020 85.7
2021 93.1
2022 109.7
2023 120.4
2024 141.5
2025 168.8
2026 188.6
2027 203.5
2028 238.6

In the year 2021, the Global Ankylosing Spondylitis Market was valued at USD 4,933.46 million. The size of this market is expected to increase to USD 8,292.04 million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of 7.7%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drug
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Ankylosing Spondylitis Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing penetration of key players in the AS market
        2. Presence of strong product pipeline
        3. Favorable reimbursement policies
      2. Restraints
        1. Patent expiry of blockbuster drugs
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global Ankylosing Spondylitis Market, By Drug, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Segment Trends
        1. Cosentyx
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        2. Humira
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        3. Simponi
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        4. Remicade
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        5. Enbrel
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        6. Cimzia
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
        7. Others
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2018 - 2028 (USD Million)
    2. Global Ankylosing Spondylitis Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2022 and 2028 (%)
      3. Y-o-Y Growth Analysis, 2019 - 2028
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drug, 2018 - 2028 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AbbVie, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Amgen, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Pfizer, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. Novartis AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      5. Eli Lilly and Company
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      6. UCB, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      7. Johnson & Johnson Services, Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      8. Merck & Co., Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market

ReAnIn's Most Viewed Titles:

Healthcare Pharmaceuticals & Therapeutics Ankylosing Spondylitis Treatment
Global Ankylosing Spondylitis Treatment Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Ankylosing Spondylitis Treatment Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Medical Devices Anomaloscope
Global Anomaloscope Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Anomaloscope Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare Pharmaceuticals & Therapeutics Anorexiants
Global Anorexiants Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Anorexiants Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...
Healthcare In Vitro Diagnostics Antenatal Screening
Global Antenatal Screening Market Growth, Share, Size, Trends and Forecast (2022 - 2028)

In the year 2021, the Global Antenatal Screening Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2028, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%

Single User License $4200 Read More ...